NYSE-listed GE announced the creation of a $250m equity vehicle that will make investments in healthcare technology companies.
The GE Healthymagination Fund will invest in promosing companies with innovative diagnostic, IT, and life sciences technologies and developing unique business models and services.
The fund will target three broad areas for investment:
– Broad-based Diagnostics, including imaging, home health, patient monitoring, molecular diagnostics, pathology, novel imaging agents and other technologies for disease diagnosis.
– Healthcare Information Technology, including electronic medical records, clinical information systems, healthcare information exchanges and value-added data services.
– Life Sciences, including tools for research and development in biopharmaceuticals and stem cells, and technologies for manufacturing of biopharmaceuticals and vaccines.
The fund will be based on capabilities coming from GE Healthcare, GE Capital and GE Global Research and will have a global presence.
The creation of the new vehicle is part of GE’s $6bn Healthymagination initiative, a global commitment to deliver better healthcare to more people at lower cost.
FinSMEs
22/10/2009